GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Resonance Health RHT.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.08

-1.30%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Resonance Health — daily ASX:RHT

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Resonance Health on TradingView ↗
Market value
A$34.6m
Last close × shares
Volume
276.4k
Shares, 9 Nov 2026
Price to earnings
22.9

About Resonance Health

Its shares trade on ASX under the ticker RHT.AX. It has been listed since 23 October 1987. In the fiscal year to 30 June 2026, it reported revenue of A$15.8m and net income of A$1.5m. At that date it held total assets of A$18.7m and shareholders' equity of A$11.1m.

Resonance Health Ltd. operates as a healthcare company, which involves in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. The company is headquartered in Perth, Western Australia. The firm's segments include Services, Research and Development, and Corporate. The firm's core product is FerriScan, which is a non-invasive liver diagnostic technology used for the measurement of iron in the liver. FerriScan is used for liver iron concentration (LIC) measurement from magnetic resonance imaging (MRI) scans of a patient's liver. The FerriScan analysis procedure produces a mean LIC measurement and a color coded map reflecting the iron distribution across the liver. The firm's product HepaFat-Scan, is a non-invasive method for measuring volumetric liver fat fraction (VLFF) from MRI scans. HepaFat-Scan is provided as an image analysis service. HepaFat-Scan is available for routine clinical use and for use in pharmaceutical company clinical trials.

Figures and description from our data supplier, not checked against the company's own report.

More about Resonance Health →

Latest on Resonance Health

Our reporting

We have not reported on Resonance Health yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Resonance Health's ticker?

Resonance Health trades as RHT.AX on ASX, under ISIN AU000000RHT2.

What was Resonance Health's last closing price?

0.08 on 9 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.